NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts18181818
Avg. Estimate0.810.942.14.6
Low estimate0.580.641.143.45
High estimate1.671.744.856.26
Year ago EPS-0.180.691.562.1
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts22222626
Avg. Estimate444.23M467.22M1.82B2.08B
Low estimate425M450M1.74B1.93B
High estimate470.63M484.6M1.88B2.23B
Year ago sales378.2M376.97M1.49B1.82B
Sales growth (year/est)17.50%23.90%22.40%14.20%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS0.60.791.150.13
Actual EPS-0.180.690.88-0.79
Difference-0.78-0.1-0.27-0.92
Surprise %-130.00%-12.70%-23.50%-707.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate0.810.942.14.6
7 days ago0.760.891.934.83
30 days ago0.760.891.934.6
60 days ago0.810.872.924.83
90 days ago0.810.872.924.84
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days111N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1111
Growth estimatesNBIXIndustrySector(s)S&P 500
Current qtr.550.00%N/AN/AN/A
Next qtr.36.20%N/AN/AN/A
Current year34.60%N/AN/AN/A
Next year119.00%N/AN/AN/A
Next 5 years (per annum)23.80%N/AN/AN/A
Past 5 years (per annum)24.08%N/AN/AN/A